Refine your search
Collections
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Sultan, Mohammad
- Case Report of Rare Entity for Atypical Hemolytic Uremic Syndrome
Abstract Views :202 |
PDF Views:84
Authors
Affiliations
1 PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Nashik – 422003, Maharashtra, IN
2 Assistant Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Nashik – 422003, Maharashtra, IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Nashik – 422003, Maharashtra, IN
1 PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Nashik – 422003, Maharashtra, IN
2 Assistant Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Nashik – 422003, Maharashtra, IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Nashik – 422003, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 7, No 1 (2020), Pagination: 129-134Abstract
Background: Atypical Haemolytic Uremic Syndrome (aHUS) is a genetic or acquired disorder of regulatory component of the complement system. It is associated with mutations in genes coding for complement components. The abnormality in components of complement makes it susceptible and predispose to chronic uncontrolled hyperactivation of the alternative complement pathway, which results in endothelial damage and microvascular thrombosis. This case report describes a patient diagnosed with Thrombotic Microangiopathy (TMA) due to factor H autoantibody having haemolytic anemia, thrombocytopenia and acute kidney injury. Patient’s anemia and renal parameters improved after treatment with plasma exchange therapy. Conclusion: Atypical HUS must be strongly suspected in any patient who presents with nonspecific abdominal or respiratory symptoms along with anemia and thrombocytopenia. As extrarenal involvement is a rare entity of aHUS, the clinician should also keep a high index of suspicion to the possibility of thrombotic microangiopathy manifestation in almost any organ system. In a suspected or diagnosed case of aHUS, the development of new non renal symptoms and signs should prompt clinician for further evaluation to rule out ongoing thrombotic microangiopathy process.Keywords
Acute Kidney Injury, aHUS, Complement, Dialysis, Plasma Exchange, Thrombotic-Microangiopathy (TMA)References
- Noris M, Remuzzi G. Atypical haemolytic uremic syndrome. New England Journal of Medicine. 2009: 1676-87. https:// doi.org/10.1056/NEJMra0902814. PMid:19846853.
- Skorecki K, Chertow G. Brenner & Rector's The kidney. 10th ed. Philadelphia. Elsevier; 2016.
- Caprioli J, Noris M, Brioschi S. Genetics of HUS: The impact of MCP, CFH and IF mutation son clinical presentation, response to treatment, and outcome. Blood. 2006; 108:1267-79. https://doi.org/10.1182/blood-2005-10007252. PMid:16621965 PMCid:PMC1895874
- Loirat C, Noris M, Fremeaure-Bacchi V. Complement and the atypical haemolytic uremic syndrome in children. Pediatric Nephrology. 2008; 23(11):1957-72. https:// doi.org/10.1007/s00467-008-0872-4. PMid:18594873 PMCid:PMC6904381
- Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. New England Journal of Medicine. 2013; 368:23:2169-81. https:// doi.org/10.1056/NEJMoa1208981. PMid:23738544.
- Bakr A. Haemolytic Uremic Syndrome in Children (19552015): A 60 Years Journey. Journal of Nephrology Research. 2015; 1:2.
- Sinha A, Gulati A, Saini S. Indian HUS Registry: Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of antifactor H autoantibody associated haemolytic uremic syndrome in children. Kidney International. 2004; 85:1151-60. https://doi.org/10.1038/ ki.2013.373. PMid:24088957
- Sibai BM. Imitators of severe pre-eclapsia/eclampsia. Clinics in Perinatology. 2004; 31:835-52. https://doi.org/10.1016/j. clp.2004.06.007. PMid:15519430.
- McCrae KR, Cines DB. Thrombotic microangiopathy during pregnancy. Seminars in Hematology. 1997; 34:148.
- A Study to Evaluate Correlation of C-Reactive Protein and Glycosylated Haemoglobin in Patients of Diabetes Suffering from Acute Coronary Syndrome
Abstract Views :158 |
PDF Views:80
Authors
Affiliations
1 Former PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, India ., IN
2 Associate Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, India ., IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, India ., IN
1 Former PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, India ., IN
2 Associate Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, India ., IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, India ., IN
Source
MVP Journal of Medical Sciences, Vol 9, No 1 (2022), Pagination: 1 - 8Abstract
Incidence of diabetes is increasing substantially worldwide. Cardiovascular disease is most prevalent cause of mortality and morbidity in diabetic populations. Cardiovascular risk factor including obesity, hypertension, dyslipidemia are common in patients with diabetes mellitus particularly with those of type 2 diabetes. Atherosclerosis has been described as an inflammatory disease. Aim: Study to evaluate correlation of C-Reactive Protein and Glycosylated Haemoglobin in Patients of Diabetes Suffering from Acute Coronary Syndrome. Material and Methods: A descriptive study after satisfying criteria was conducted in 115 patients in medicine department of a medical college and tertiary care hospital over a period of two years that included patients of diabetes suffering from acute coronary syndrome in the age group of 30 to 70 years. Evaluation and correlation was done by clinical profile. Results: Majority of patients were elderly age group of male of 51 to 60 yrs having mean BMI of 24 kg/m2 . CRP level of >3 mg/dl was found in 77.39% and majority of patients had HbA1C >7%. CRP and HbA1C were significantly correlated (p<0.05). Majority of patients with elevated CRP were found in with killip class I. But CRP and killip classification were not significantly correlated in our study. Conclusion: Elevated C Reactive Protein and Glycosylated Haemoglobin are better correlated as poor prognostic marker for cardiovascular event in patients of diabetes suffering from acute coronary syndrome.Keywords
CAD, Cholesterol, CRP, Diabetes, HbA1cReferences
- Wild S, Roglic G, Green A. Global prevalence of diabetes: Estimate for the year 2000 and projection for 2030 Diabetes care. 2004. https://doi.org/10.2337/diacare.27.10.2569-a
- Matheus AS, Tannus LR, Cobasra RA. Impact of diabetes on cardiovascular disease: An update. Int J Hypertens. 2013: 653789. PMid: 23533715 PMCid: PMC3603160.https://doi.org/10.1155/2013/653789
- Yudkin JS, Blauth C, Drury P. Prevention and management of cardiovascular disease in patients with diabetes mellitus: An evidence base. Diabetic Med. 1996; 13: S101–21.
- Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999; 340: 115–26. PMid: 9887164. https://doi.org/10.1056/NEJM199901143400207
- Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967; 20(4): 457–64. https://doi.org/10.1016/0002-9149(67)90023-9
- Nyandak T, Gogna A, Bansal S. High sensitive C-Reactive Protein (hs-CRP) and its correlation with Angiographic Severity of Coronary Artery Disease (CAD). JIACM. 2007; 8(3): 217–21.
- Khaw KT, Wareham N, Bingham S. Jet powered engines. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004; 141: 413–20. PMid: 15381514. https://doi.org/10.7326/0003-4819-141-6-200409210-00006
- Sasidharan A, Krishnamurthy A, Tagore S. C-Reactive Protein and glycemic control in adults with type 2 diabetes mellitus. Journal of Medicine, Radiology, Pathology and Surgery. 2016; 2: 10–3. https://doi.org/10.15713/ins.jmrps.56
- Abdul Razzaq MK, Rasheed JI, Mohmmad HS. The value of admission glucose and glycosylated hemoglobin in patients with acute coronary syndrome. The Iraqi Postgraduate Medical Journal. 2013; 12(1).
- Babu LE, Joshi A. Correlation of high-sensitivity C-Reactive Protein with blood sugar level in patients with Type 2 diabetes. National Journal of Physiology, Pharmacy and Pharmacology. 2018; 8(7): 37–41. https://doi.org/10.5455/ njppp.2018.8.0726805082017
- Singh S, Bansal M, Rani K. Prognostic significance of Glycosylated Hemoglobin in Nondiabetic Patients in Acute Coronary Syndrome. Heart India. 2016; 4(1): 17-22.
- Pasupathi P, Raoa YY, Farook J. The combinational effect of cardiac and biochemical markers in diabetic patients with cardiovascular disease. Int J Cur Bio Med Sci. 2011; 1(2): 30–4.
- Mani VE, John M, Rajneesh Calton. Impact of HbA1c on Acute Cardiac States. (Accessed [Last received on: 2009 Dec 03; Last revised on 2010 Feb 03; Last accepted on 2010 Feb 05]). http://www.japi.org/ june_2011/article_03.pdf
- Selvin E, Marinopoulos S, Berkenblit G. Meta-analysis: Glycosylated Haemoglobin and cardiovascular disease in diabetes mellitus. 2004; 141: 421–31. PMid: 15381515. https://doi.org/10.7326/0003-4819-141-6-20040921000007
- Malmberg K, Norhammar A, Wedel H. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999; 99: 2626 –32. PMid: 10338454. https://doi.org/10.1161/01.CIR.99.20.2626 .
- Basar GS. CAGE - Study of C-Reactive Protein and Glycosylated Haemoglobin in adult type 2 diabetes
- mellitus. 3rd World Congress on Diabetes and Metabolism. 2010; 32.
- King DE, Mainous AG3rd, Buchanan TA, Pearson WS. C-Reactive Protein and glycemic control in adults with diabetes. Diabetes Care. 2003; 26(5): 1535–9. PMid: 12716818. https://doi.org/10.2337/diacare.26.5.1535 .